Japan · Delayed Price · Currency is JPY Riken Vitamin Statistics
Total Valuation
Riken Vitamin has a market cap or net worth of JPY 85.02 billion. The enterprise value is 72.14 billion.
| Market Cap | 85.02B |
| Enterprise Value | 72.14B |
Important Dates
The last earnings date was Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Riken Vitamin has 29.19 million shares outstanding. The number of shares has decreased by -2.45% in one year.
| Current Share Class | 29.19M |
| Shares Outstanding | 29.19M |
| Shares Change (YoY) | -2.45% |
| Shares Change (QoQ) | -0.61% |
| Owned by Insiders (%) | 11.16% |
| Owned by Institutions (%) | 27.82% |
| Float | 21.38M |
Valuation Ratios
The trailing PE ratio is 12.23 and the forward PE ratio is 13.62.
| PE Ratio | 12.23 |
| Forward PE | 13.62 |
| PS Ratio | 0.88 |
| PB Ratio | 1.02 |
| P/TBV Ratio | 1.03 |
| P/FCF Ratio | 77.29 |
| P/OCF Ratio | 14.26 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.23, with an EV/FCF ratio of 65.58.
| EV / Earnings | 10.25 |
| EV / Sales | 0.75 |
| EV / EBITDA | 6.23 |
| EV / EBIT | 10.45 |
| EV / FCF | 65.58 |
Financial Position
The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.41 |
| Quick Ratio | 2.20 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.62 |
| Debt / FCF | 6.49 |
| Interest Coverage | 60.54 |
Financial Efficiency
Return on equity (ROE) is 8.66% and return on invested capital (ROIC) is 6.64%.
| Return on Equity (ROE) | 8.66% |
| Return on Assets (ROA) | 3.76% |
| Return on Invested Capital (ROIC) | 6.64% |
| Return on Capital Employed (ROCE) | 7.12% |
| Weighted Average Cost of Capital (WACC) | 4.00% |
| Revenue Per Employee | 51.83M |
| Profits Per Employee | 3.79M |
| Employee Count | 1,858 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 3.19 |
Taxes
In the past 12 months, Riken Vitamin has paid 3.20 billion in taxes.
| Income Tax | 3.20B |
| Effective Tax Rate | 31.28% |
Stock Price Statistics
The stock price has increased by +11.52% in the last 52 weeks. The beta is -0.00, so Riken Vitamin's price volatility has been lower than the market average.
| Beta (5Y) | -0.00 |
| 52-Week Price Change | +11.52% |
| 50-Day Moving Average | 2,831.98 |
| 200-Day Moving Average | 2,920.39 |
| Relative Strength Index (RSI) | 63.34 |
| Average Volume (20 Days) | 119,920 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Riken Vitamin had revenue of JPY 96.30 billion and earned 7.04 billion in profits. Earnings per share was 238.17.
| Revenue | 96.30B |
| Gross Profit | 29.77B |
| Operating Income | 6.90B |
| Pretax Income | 10.24B |
| Net Income | 7.04B |
| EBITDA | 11.58B |
| EBIT | 6.90B |
| Earnings Per Share (EPS) | 238.17 |
Balance Sheet
The company has 20.07 billion in cash and 7.14 billion in debt, with a net cash position of 12.93 billion or 442.96 per share.
| Cash & Cash Equivalents | 20.07B |
| Total Debt | 7.14B |
| Net Cash | 12.93B |
| Net Cash Per Share | 442.96 |
| Equity (Book Value) | 83.38B |
| Book Value Per Share | 2,855.27 |
| Working Capital | 46.79B |
Cash Flow
In the last 12 months, operating cash flow was 5.96 billion and capital expenditures -4.86 billion, giving a free cash flow of 1.10 billion.
| Operating Cash Flow | 5.96B |
| Capital Expenditures | -4.86B |
| Depreciation & Amortization | 4.68B |
| Net Borrowing | -2.77B |
| Free Cash Flow | 1.10B |
| FCF Per Share | 37.69 |
Margins
Gross margin is 30.91%, with operating and profit margins of 7.17% and 7.31%.
| Gross Margin | 30.91% |
| Operating Margin | 7.17% |
| Pretax Margin | 10.64% |
| Profit Margin | 7.31% |
| EBITDA Margin | 12.02% |
| EBIT Margin | 7.17% |
| FCF Margin | 1.14% |
Dividends & Yields
This stock pays an annual dividend of 110.00, which amounts to a dividend yield of 3.78%.
| Dividend Per Share | 110.00 |
| Dividend Yield | 3.78% |
| Dividend Growth (YoY) | 17.02% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 46.08% |
| Buyback Yield | 2.45% |
| Shareholder Yield | 6.22% |
| Earnings Yield | 8.27% |
| FCF Yield | 1.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 30, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Mar 30, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Riken Vitamin has an Altman Z-Score of 3.85 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.85 |
| Piotroski F-Score | 6 |